Sarcoidosis bowel symptoms

Sarcoidosis bowel symptoms DEFAULT

Gastric sarcoidosis mimicking irritable bowel syndrome-Cause not association?

1. Mitchell D. Sarcoidosis. Medicine. 1998;26:43–49.[Google Scholar]

2. Fireman Z, Sternberg A, Yarchovsky Y, Abu-Much S, Coscas D, Topilsky M, Fireman E, Groisman GM. Multiple antral ulcers in gastric sarcoid. J Clin Gastroenterol. 1997;24:97–99. [PubMed] [Google Scholar]

3. Moretti AM, Sallustio G, Attimonelli R, Arezzo C, Neri D, Losito A. [Gastric localization of sarcoidosis] Recenti Prog Med. 1993;84:750–755. [PubMed] [Google Scholar]

4. Sprague R, Harper P, McClain S, Trainer T, Beeken W. Disseminated gastrointestinal sarcoidosis. Case report and review of the literature. Gastroenterology. 1984;87:421–425. [PubMed] [Google Scholar]

5. Chinitz MA, Brandt LJ, Frank MS, Frager D, Sablay L. Symptomatic sarcoidosis of the stomach. Dig Dis Sci. 1985;30:682–688. [PubMed] [Google Scholar]

6. Tinker MA, Viswanathan B, Laufer H, Margolis IB. Acute appendicitis and pernicious anemia as complications of gastrointestinal sarcoidosis. Am J Gastroenterol. 1984;79:868–872. [PubMed] [Google Scholar]

7. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut. 1999;45 Suppl 2:II43–II47.[PMC free article] [PubMed] [Google Scholar]

8. Palmer ED. Note on silent sarcoidosis of the gastric mucosa. J Lab Clin Med. 1958;52:231–234. [PubMed] [Google Scholar]

9. Bratkovskiĭ MV, Magalif NI. [Sarcoidosis of the stomach] Probl Tuberk. 1990:28–30. [PubMed] [Google Scholar]

10. Farman J, Ramirez G, Rybak B, Lebwohl O, Semrad C, Rotterdam H. Gastric sarcoidosis. Abdom Imaging. 1997;22:248–252. [PubMed] [Google Scholar]

11. Hogg SG. Case report: gastric sarcoid simulating linitis plastica--a 5-year follow-up study. Clin Radiol. 1991;44:277–278. [PubMed] [Google Scholar]

12. Roth D, West B, Madison J, Cooper D. Gastric carcinoma in a patient with sarcoidosis of the gastrointestinal tract. Am J Gastroenterol. 1994;89:1589–1591. [PubMed] [Google Scholar]

13. Reynolds HY. Sarcoidosis: impact of other illnesses on the presentation and management of multi-organ disease. Lung. 2002;180:281–299. [PubMed] [Google Scholar]

14. Sanders DS, Carter MJ, Hurlstone DP, Pearce A, Ward AM, McAlindon ME, Lobo AJ. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet. 2001;358:1504–1508. [PubMed] [Google Scholar]

15. McCormick PA, Feighery C, Dolan C, O'Farrelly C, Kelliher P, Graeme-Cook F, Finch A, Ward K, Fitzgerald MX, O'Donoghue DP. Altered gastrointestinal immune response in sarcoidosis. Gut. 1988;29:1628–1631.[PMC free article] [PubMed] [Google Scholar]

16. Vanhagen PM, Krenning EP, Reubi JC, Kwekkeboom DJ, Bakker WH, Mulder AH, Laissue I, Hoogstede HC, Lamberts SW. Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med. 1994;21:497–502. [PubMed] [Google Scholar]

17. Sachar DB, Rochester J. The myth of gastrointestinal sarcoidosis: a case of guilt by association. Inflamm Bowel Dis. 2004;10:441–443. [PubMed] [Google Scholar]

Sours: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087846/

Sir,

Sarcoidosis is an immune-mediated condition affecting multiple organs, especially the lungs, lymph nodes, skin and eyes.1,2 Gastrointestinal involvement is considered to be a rare complication of sarcoidosis, occurring in <10% of the patients during the course of the disease.3,4 We recently observed the interesting case of a patient who developed duodenal involvement as the first manifestation of sarcoidosis.

A 36-year-old woman, with unremarkable previous medical history, presented with a 4-month history of asthenia and a 10-kg weight loss; she also complained of abdominal pain, diarrhea and arthralgia. At admission, physical examination demonstrated abdominal pain to palpation, involving the epigastric area; general physical examination was otherwise normal. Laboratory findings disclosed the following: erythrocyte sedimentation rate 66 mm/h; C-reactive protein 25 mg/l; hemoglobin 12 g/dl; white blood cell count 9.1 × 109/l; and platelet count 450 × 109/l. Other routine biochemical tests, including renal and liver tests, vitamin B12 and folic acid blood levels, as well as blood and urinary protein immunoelectrophoresis, were normal. Stool cultures (Yersinia, Salmonella, Camplylobacter and Shigella) yielded negative results. Because of abdominal clinical manifestations, gastroscopy was performed, which showed granulomatous duodenal involvement (Figure 1). Histological examination of duodenal lesion specimens showed numerous non-caseating epithelioid granulomas; there was no evidence of Helicobacter pylori. Special stains and cultures of the duodenum biopsy specimens were negative for Mycobacterium species and fungi; polymerase chain reaction amplification of Mycobacterium tuberculosis complex and bacterial 16S ribosomal RNA further proved negative. Tuberculin skin test was negative; further microbiological studies (Ziehl–Neelsen stain and cultures) in sputum and urine products were also negative for acid-fast bacilli. Thoracic and abdominal computed tomography-scan showed bilateral hilar lymphadenopathy. Pulmonary function tests revealed a mild decrease of diffusing capacity for carbon monoxide (68%) without restrictive pattern. Bronchoscopy was systematically performed; histological examination also showed numerous non-caseating epithelioid granulomas. Bacterial (Treponema pallidum) and viral (cytomegalovirus, Epstein–Barr virus, Herpes simplex virus, hepatitis B and C, human immunodeficiency virus) were negative. Autoantibody screening also yielded negative results for rheumatoid factors, anti-nuclear and anti-neutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisae antibodies, anti-endomysium and anti-transglutaminase antibodies; serum angiotensin-converting enzyme level was elevated: 97 IU/l (n < 68). Other investigations, including accessory salivary gland histological examination, colonoscopy and small bowel barium meal were normal. A definite diagnosis of small intestinal involvement related to sarcoidosis was made. Because of the systemic manifestations related to sarcoidosis, steroid therapy, at an initial dose of 30 mg daily was initiated. The patient's condition improved rapidly with regression of clinical symptoms and weight gain.

Gastrointestinal involvement is rare in sarcoidosis. Previous autopsy series have, in fact, found no gastrointestinal impairment in patients with sarcoidosis,5 while other authors have observed subclinical gastrointestinal sarcoidosis in 5–10% of the patients.2,3 The stomach, particularly the antrum, is the most frequent extra-hepatic organ to be involved; on the other hand, the small intestine is the least common.2,3 Intestinal involvement usually occurs in patients with chronic multisystem sarcoidosis, although it may be the first manifestation of the disease;2,3 in our patient, small bowel impairment revealed sarcoidosis. Clinical manifestations of sarcoidosis-related intestinal impairment are non-specific, including epigastric and peri-umbilical pain, diarrhea, weight loss, malabsorption, protein-losing enteropathy or duodenal obstruction.2,3,6,7 Nevertheless, the definite diagnosis of sarcoidosis-related small intestinal impairment can only be established after exclusion of other conditions.8 In our patient, a diagnosis of sarcoidosis-related small intestinal involvement could be made as: (i) the extensive search for other conditions was unsuccessful, including infections (tuberculosis, Whipple's disease and syphilis), Crohn's disease, celiac disease, foreign body reaction, autoimmune diseases, as well as drug-related lesions and malignancy (lymphoma, carcinoma); (ii) there was a combination of the histological granulomatous duodenal involvement and the pulmonary lesions; and (iii) the resolution of clinical manifestations took place after initiation of steroid therapy. Our findings underline that when unexplained intestinal manifestations are noted, careful clinical examination should systematically be performed in order to detect underlying sarcoidosis. Moreover, our data also indicate that patients with sarcoidosis who exhibit persistent diarrhea and abdominal pain should be investigated for intestinal sarcoidosis. Therapy of sarcoidosis-related small intestinal involvement remains controversial. Previous authors have suggested that steroids should be considered in the group of the patients who exhibit: (i) symptomatic intestinal lesions and (ii) intestinal involvement associated with multivisceral and severe sarcoidosis. The recommended starting dose of steroid therapy is 20–40 mg daily, with gradual dose decrease subsequently.9,10 Steroid therapy has been reported to improve intestinal gastrointestinal symptoms in 66% of the patients. 9,10

Finally, our case report reinforces the possibility of an unusual presentation of sarcoidosis. Indeed, physicians should be aware that small bowel involvement may be related to sarcoidosis, resulting in earlier diagnosis and management. In such patients exhibiting unusual intestinal manifestations, diagnosis of sarcoidosis relies on compatible clinical signs, evidence of non-caseating granulomas and exclusion of underlying conditions, especially infections and other granulomatous diseases. Moreover, because small intestinal involvement may precede other signs of sarcoidosis, our findings indicate that when unexplained intestinal involvement is noted, an evaluation for sarcoidosis should be made.

References

1
,  ,  ,  ,  ,  , et al. 

Sinonasal involvement in sarcoidosis. A case-control study of 20 patients

Medicine

2006

, vol. 

85

 (pg. 

365

-

71

)
5
,  . 

A study of sarcoidosis based on a combined investigation of 160 cases including 30 autopsies from the Johns Hopkins Hospital and Massacussetts General Hospital

Medicine

1952

, vol. 

31

 (pg. 

1

-

132

)
10
,  ,  ,  ,  ,  , et al. 

Multiple antral ulcers in gastric sarcoid

J Clin Gastroenterol

1997

, vol. 

24

 (pg. 

97

-

9

)

© The Author 2009. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: [email protected]

Download all slides

Sours: https://academic.oup.com/qjmed/article/103/1/60/1538737
  1. Vcf number
  2. Empire galactic survival
  3. Mushroom frog wallpaper
  4. Dog clipart

Sarcoidosis Could Be Cause of Digestive Tract Ailments Especially in Afro-Caribbeans, Study Suggests

Weight loss and digestive symptoms such as nausea, vomiting, diarrhea, and digestive bleeding could be linked to digestive tract sarcoidosis (DTS), especially in patients of African and Afro-Caribbean origin, according to a study conducted by researchers in France. DTS should therefore be considered in the presence of these symptoms, and in every patient with digestive granulomatosis.

The team analyzed 25 patients with DTS (more than 50 percent of whom were of African or Afro-Caribbean origin), and compared the characteristics of the disease with 50 patients with non-digestive tract sarcoidosis, and 100 controls with Crohn’s disease (an inflammatory bowel disease).

Researchers found that people with DTS had no swollen lymph nodes in their chest, but instead had lesions mainly in the stomach and also in the colon, rectum, and, to a lesser extent, in the esophagus and in the duodenum (the first section of the small intestine).

Even though sarcoidosis mainly affects lungs and chest lymph nodes, in very rare cases (01 percent to 1.6 percent) it can also involve the digestive tract. Because the presence of granulomas in the digestive system is mainly associated with Crohn’s disease, the researchers compared DTS with Crohn’s disease to determine the characteristics that could differentiate these two conditions.

The team found that DTS more often involved the upper digestive tract, especially the stomach, while patients with Crohn’s disease more often had lesions in the ileum (the final section of the small intestine), and the colon. In addition, patients with DTS often had other complications, such as interstitial lung disease, swollen lymph nodes, granulomatous hepatitis, high calcium levels in the blood, and central nervous system or heart involvement, which are not typically seen in Crohn’s disease.

Interestingly, DTS was more frequently observed in African or Afro-Caribbean patients compared to Crohn’s disease.

“The absence of ileal or colonic involvement in a patient with a granulomatous digestive tract disease, especially with an African or Afro-Caribbean origin, must encourage considering the diagnosis of sarcoidosis,” the research team wrote in their report.

In the last follow-up assessment performed, 76 percent of the patients with DTS recovered by themselves (clinical digestive remission) and did not need surgery, while a third of the patients with Crohn’s disease did require a surgical intervention.

“The differential diagnosis with Crohn’s disease could be an issue with DTS. Nevertheless, the two diseases often have different clinical presentation and outcome,” the research team concluded.

The study, “Digestive-tract sarcoidosis: French nationwide case–control study of 25 cases,” was published in the journal Medicine.

Sours: https://sarcoidosisnews.com/2016/07/26/sarcoidosis-cause-digestive-tract-problems-afro-caribbeans/
Sarcoidosis, Causes, Signs and Symptoms, Diagnosis and Treatment.

Digestive-tract sarcoidosis

1. Valeyre D, Prasse A, Nunes H, et al. Sarcoidosis. Lancet 2014; 383:1155–1167. [PubMed] [Google Scholar]

2. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164:1885–1889. [PubMed] [Google Scholar]

3. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357:2153–2165. [PubMed] [Google Scholar]

4. Morimoto T, Azuma A, Abe S, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J 2008; 31:372–379. [PubMed] [Google Scholar]

5. Farman J, Ramirez G, Rybak B, et al. Gastric sarcoidosis. Abdom Imaging 1997; 22:248–252. [PubMed] [Google Scholar]

6. Ebert EC, Kierson M, Hagspiel KD. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol 2008; 103:3184–3192.quiz 3193. [PubMed] [Google Scholar]

7. Vahid B, Spodik M, Braun KN, et al. Sarcoidosis of gastrointestinal tract: a rare disease. Dig Dis Sci 2007; 52:3316–3320. [PubMed] [Google Scholar]

8. Shapiro JL, Goldblum JR, Petras RE. A clinicopathologic study of 42 patients with granulomatous gastritis. Is there really an « idiopathic » granulomatous gastritis?Am J Surg Pathol 1996; 20:462–470. [PubMed] [Google Scholar]

9. Bernstein CN, Blanchard JF, Rawsthorne P, et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001; 96:1116–1122. [PubMed] [Google Scholar]

10. Statement on sarcoidosis.. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160:736–755. [PubMed] [Google Scholar]

11. Maàmouri N, Guellouz S, Ben Hariz F, et al. Gastrointestinal sarcoidosis. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne 2010; 31:262–267. [Google Scholar]

12. Holman GA, Kolendich KM. Gastric sarcoidosis in the setting of chronic lymphocytic leukemia. Dig Dis Sci 2014; 59:35–38. [PubMed] [Google Scholar]

13. Pearce J, Ehrlich A. Gastric sarcoidosis. Ann Surg 1955; 141:115–119. [PMC free article] [PubMed] [Google Scholar]

14. Bat T, Morgan CM, Marx R, et al. Colon sarcoidosis presenting with abdominal pain. Endoscopy 2014; 46(Suppl 1 UCTN):E121. [PubMed] [Google Scholar]

15. Shkolnik LE, Shin RD, Brabeck DM, et al. Symptomatic gastric sarcoidosis in a patient with pulmonary sarcoidosis in remission. BMJ Case Rep 2012; 2012. [PMC free article] [PubMed] [Google Scholar]

16. Samarasena JB, Chu E, Muthusamy VR. An African American man with dysphagia: a unique initial presentation of sarcoidosis. Endoscopy 2012; 44(Suppl 2 UCTN):E63–64. [PubMed] [Google Scholar]

17. Inomata M, Ikushima S, Awano N, et al. Upper gastrointestinal sarcoidosis: report of three cases. Intern Med Tokyo Jpn 2012; 51:1689–1694. [PubMed] [Google Scholar]

18. Hunjan T, Chaudery M, Zaidi A, et al. Appendicular sarcoidosis mimicking acute appendicitis. BMJ Case Rep 2012; 2012. [PMC free article] [PubMed] [Google Scholar]

19. Esmadi M, Ahmad DS, Odum B, et al. Sarcoidosis: an extremely rare cause of granulomatous enterocolitis. J Gastrointest Liver Dis JGLD 2012; 21:423–425. [PubMed] [Google Scholar]

20. Tsujino T, Ito Y, Yoshida H, et al. Duodenal mass in a patient with weight loss and liver dysfunction. Duodenal and liver sarcoidosis. Gut 2011; 60:1659–1660.1677. [PubMed] [Google Scholar]

21. Bredenoord AJ, Jafari J, Kadri S, et al. Case report: achalasia-like dysmotility secondary to oesophageal involvement of sarcoidosis. Gut 2011; 60:153–155. [PubMed] [Google Scholar]

22. Ziora D, Trzepióra B, Kozielski J. Gastric sarcoidosis – a case report. Pneumonol Alergol Pol 2010; 78:374–378. [PubMed] [Google Scholar]

23. Ushiki A, Koizumi T, Kubo K, et al. Colonic sarcoidosis presenting multiple submucosal tumor-like lesions. Intern Med Tokyo Jpn 2009; 48:1813–1816. [PubMed] [Google Scholar]

24. Marie I, Sauvetre G, Levesque H. Small intestinal involvement revealing sarcoidosis. QJM Mon J Assoc Physicians 2010; 103:60–62. [PubMed] [Google Scholar]

25. Friedman M, Ali MA, Borum ML. Gastric sarcoidosis: a case report and review of the literature. South Med J 2007; 100:301–303. [PubMed] [Google Scholar]

26. Boyum RD, Yeung KJA, Kaplan KJ, et al. Pediatric gastrointestinal sarcoidosis presenting with protein-losing enteropathy. J Pediatr Gastroenterol Nutr 2007; 44:152–156. [PubMed] [Google Scholar]

27. Brunner J, Sergi C, Müller T, et al. Juvenile sarcoidosis presenting as Crohn's disease. Eur J Pediatr 2006; 165:398–401. [PubMed] [Google Scholar]

28. Doudier B, Schleinitz N, Hardwigssen J, et al. Digestive sarcoïdosis: an unusual case revealed by acute ileocecal invagination. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne 2003; 24:700–702. [PubMed] [Google Scholar]

29. Beniwal RS, Cummings OW, Cho WK. Symptomatic gastrointestinal sarcoidosis: case report and review of the literature. Dig Dis Sci 2003; 48:174–178. [PubMed] [Google Scholar]

30. Lukens FJ, Machicao VI, Woodward TA, et al. Esophageal sarcoidosis: an unusual diagnosis. J Clin Gastroenterol 2002; 34:54–56. [PubMed] [Google Scholar]

31. Marcato N, Abergel A, Froment S, et al. Sarcoidosis gastropathy: diagnosis and contribution of echo-endoscopy. Gastroentérologie Clin Biol 1999; 23:394–397. [PubMed] [Google Scholar]

32. Takashima M, Hanai H, Sato Y, et al. Association of Crohn's ileitis with pulmonary and cutaneous sarcoidosis in a Japanese patient. Gastrointest Endosc 1998; 48:637–639. [PubMed] [Google Scholar]

33. Dumot JA, Adal K, Petras RE, et al. Sarcoidosis presenting as granulomatous colitis. Am J Gastroenterol 1998; 93:1949–1951. [PubMed] [Google Scholar]

34. Fireman Z, Sternberg A, Yarchovsky Y, et al. Multiple antral ulcers in gastric sarcoid. J Clin Gastroenterol 1997; 24:97–99. [PubMed] [Google Scholar]

35. Hilzenrat N, Spanier A, Lamoureux E, et al. Colonic obstruction secondary to sarcoidosis: nonsurgical diagnosis and management. Gastroenterology 1995; 108:1556–1559. [PubMed] [Google Scholar]

36. Parlier G, Josset P, Charritat JL, et al. Sarcoidosis in children with digestive manifestations. Arch Pédiatrie Organe Off Sociéte Fr Pédiatrie 1996; 3:141–143. [PubMed] [Google Scholar]

37. MacRury SM, McQuaker G, Morton R, et al. Sarcoidosis: association with small bowel disease and folate deficiency. J Clin Pathol 1992; 45:823–825. [PMC free article] [PubMed] [Google Scholar]

38. Levine MS, Ekberg O, Rubesin SE, et al. Gastrointestinal sarcoidosis: radiographic findings. AJR Am J Roentgenol 1989; 153:293–295. [PubMed] [Google Scholar]

39. Panella VS, Katz S, Kahn E, et al. Isolated gastric sarcoidosis. Unique remnant of disseminated disease. J Clin Gastroenterol 1988; 10:327–331. [PubMed] [Google Scholar]

40. Gallagher P, Harris M, Turnbull FW, et al. Gastric sarcoidosis. J R Soc Med 1984; 77:837–839. [PMC free article] [PubMed] [Google Scholar]

41. Munt PW. Sarcoidosis of the appendix presenting as appendiceal perforation and abscess. Chest 1974; 66:295–297. [PubMed] [Google Scholar]

42. Gould SR, Handley AJ, Barnardo DE. Rectal and gastric involvement in a case of sarcoidosis. Gut 1973; 14:971–973. [PMC free article] [PubMed] [Google Scholar]

43. Davies RJ. Dysphagia, abdominal pain, and sarcoid granulomata. Br Med J 1972; 3:564–565. [PMC free article] [PubMed] [Google Scholar]

44. Donoghue HD, Holton J. Intestinal tuberculosis. Curr Opin Infect Dis 2009; 22:490–496. [PubMed] [Google Scholar]

45. Sorrentino D, Avellini C, Zearo E. Colonic sarcoidosis, infliximab, and tuberculosis: a cautionary tale. Inflamm Bowel Dis 2004; 10:438–440. [PubMed] [Google Scholar]

46. Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG World Assoc Sarcoidosis Granulomatous Disord 2012; 29:119–127. [PubMed] [Google Scholar]

47. Tinker MA, Viswanathan B, Laufer H, et al. Acute appendicitis and pernicious anemia as complications of gastrointestinal sarcoidosis. Am J Gastroenterol 1984; 79:868–872. [PubMed] [Google Scholar]

48. Nunes H, Bouvry D, Soler P, et al. Sarcoidosis. Orphanet J Rare Dis 2007; 2:46. [PMC free article] [PubMed] [Google Scholar]

49. Little BP. Sarcoidosis: overview of pulmonary manifestations and imaging. Semin Roentgenol 2015; 50:52–64. [PubMed] [Google Scholar]

50. Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39:690–697. [PMC free article] [PubMed] [Google Scholar]

51. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411:599–603. [PubMed] [Google Scholar]

52. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet 2001; 29:19–20. [PubMed] [Google Scholar]

53. Rosé CD, Pans S, Casteels I, et al. Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes. Rheumatol Oxf Engl 2015; 54:1008–1016. [PubMed] [Google Scholar]

54. Kanazawa N, Okafuji I, Kambe N, et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 2005; 105:1195–1197. [PubMed] [Google Scholar]

55. Franke A, Fischer A, Nothnagel M, et al. Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2. Gastroenterology 2008; 135:1207–1215. [PubMed] [Google Scholar]

56. Fischer A, Nothnagel M, Franke A, et al. Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes. Eur Respir J 2011; 37:610–616. [PubMed] [Google Scholar]

57. Rybicki BA, Walewski JL, Maliarik MJ, et al. ACCESS Research Group. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet 2005; 77:491–499. [PMC free article] [PubMed] [Google Scholar]

58. Li Y, Wollnik B, Pabst S, et al. BTNL2 gene variant and sarcoidosis. Thorax 2006; 61:273–274. [PMC free article] [PubMed] [Google Scholar]

59. Adrianto I, Lin CP, Hale JJ, et al. Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility. PloS One 2012; 7:e43907. [PMC free article] [PubMed] [Google Scholar]

60. Prescott NJ, Lehne B, Stone K, et al. Pooled sequencing of 531 genes in inflammatory bowel disease identifies an associated rare variant in BTNL2 and implicates other immune related genes. PLoS Genet 2015; 11:e1004955. [PMC free article] [PubMed] [Google Scholar]

61. Hong SN, Park C, Park SJ, et al. Deep resequencing of 131 Crohn's disease associated genes in pooled DNA confirmed three reported variants and identified eight novel variants. Gut 2015. [PubMed] [Google Scholar]

62. Kallel L, Fekih M, Ben Ghorbel I, et al. A rare case of systemic sarcoidosis followed by Crohn's disease: a fortuitous association or etiopathogenic link?Presse Médicale Paris Fr 1983 2010; 39:148–150. [PubMed] [Google Scholar]

63. Fiorino G, Bonifacio C, Peyrin-Biroulet L, et al. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease. Inflamm Bowel Dis 2011; 17:1073–1080. [PubMed] [Google Scholar]

64. Siddiki HA, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR Am J Roentgenol 2009; 193:113–121. [PubMed] [Google Scholar]

65. Leroy C, Girard C, Girard-Madoux M-H, et al. An unusual case of duodenal sarcoidosis. Rev Med Interne Fondee Par Soc Natl Francaise Med Interne 2015. [Google Scholar]

66. Baughman RP, Drent M, Kavuru M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006; 174:795–802. [PubMed] [Google Scholar]

67. Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J 2008; 31:1189–1196. [PubMed] [Google Scholar]

Sours: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265782/

Symptoms sarcoidosis bowel

.

Understanding Sarcoidosis: A Visual Guide for Students

.

You will also like:

.



445 446 447 448 449